Colgate-Palmolive stock sits 1.88 percent below its 52-week high

Published on 10/16/2026 at 15:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results come October 30, 2026. Colgate-Palmolive stock costs EUR 83.40 on October 16, 2026, down 0.29 percent versus the Xetra close.

Price position and upcoming results

Colgate-Palmolive stock stood 1.88 percent below its 52-week high on October 16, 2026.
The company will hold its third-quarter earnings call on October 30, 2026.
Colgate-Palmolive stock costs EUR 83.40 at Lang & Schwarz on October 16, 2026 at 3:39 p.m. CEST, down 0.29 percent versus the Xetra close of October 15, 2026.
UBS set a USD 106.00 target on October 15, 2026, 13.25 percent above the USD 93.60 primary-market price.

CGI-Render eines modernen Unternehmensgebäudes mit Glasfassade und Grünanlage — Colgate-Palmolive Hauptquartier US1941621039 als moderner Glasturm mit Spiegelteich im fotorealistischen CGI-Architektur-Render dargestellt, Illustration mit AI erstellt.

Colgate-Palmolive stock stood 1.88 percent below its 52-week high on October 16, 2026, putting the consumer-products company near the upper end of its EUR 64.53 to EUR 85.00 52-week range. At 3:39 p.m. CEST, the stock was trading at EUR 83.40 at Lang & Schwarz, down 0.29 percent versus the Xetra close of October 15, 2026.

Third-quarter results on October 30, 2026

The next scheduled earnings event is the third-quarter conference call on October 30, 2026, at 8:30 a.m. ET. Business Wire reported that Colgate-Palmolive will provide the webcast, giving investors a fixed date for the next results update.

Second-quarter revenue reached USD 5.36 billion

For the second quarter of 2026, revenue was USD 5.36 billion and net income attributable to common shareholders was USD 693.00 million. The latest release from Business Wire said second-quarter net sales increased 4.90 percent year over year, while GAAP diluted earnings per share fell 5.00 percent to USD 0.86. That mix leaves the October results as the next test of whether sales growth can translate into stronger reported earnings.

Valuation and next earnings date

Colgate-Palmolive had a USD 74.6 billion market capitalization and a trailing P/E ratio of 37.12 as of October 16, 2026. On October 15, 2026, UBS analyst Peter Grom maintained a Buy rating and set a USD 106.00 target, according to Markets Insider. Against the USD 93.60 primary-market price, that target was 13.25 percent higher.

Comparison with peers

Figures below are as of October 16, 2026.

Colgate-Palmolive (NYSE, USD): minus 0.29 percent, P/E 37.12, market capitalization USD 74.6 billion
The Procter & Gamble Company (NYSE, USD): plus 1.46 percent, P/E 24.11, market capitalization USD 370.2 billion
Kimberly-Clark Corporation (NYSE, USD): plus 1.28 percent, P/E 17.94, market capitalization USD 35.1 billion

Euro quote versus Xetra

The Lang & Schwarz quote stood at EUR 83.40 on October 16, 2026 at 3:39 p.m. CEST. This was EUR 0.24 below the Xetra close of October 15, 2026, which stood at EUR 83.64. The further course of trading is shown by the continuously updated real-time quote of Colgate-Palmolive stock.